Lexology April 16, 2024
Hall Render Killian Heath & Lyman PC

On April 1, 2024, the U.S. Department of Health and Human Services (“HHS”), through the Centers for Medicare & Medicaid Services (“CMS”) released a memorandum to state survey agency directors highlighting revisions and clarification to the Hospital Interpretive Guidelines for Informed Consent (the “Guidance”). The Guidance clarifies informed consent requirements for the performance of pelvic, breast, prostate and rectal examinations (referred to in the Guidance as “sensitive exams”), particularly on patients under anesthesia.

In a letter addressed to the nation’s teaching hospitals and medical schools announcing the Guidance, HHS Secretary Xavier Becerra highlighted media reports and scientific literature on the practice of allowing medical students and residents to perform sensitive exams on patients under anesthesia for training purposes without first...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, HHS, Patient / Consumer, Provider, States
Plate tectonics and the new CMS prior authorization rule | Viewpoint
DACA recipients eligible for Affordable Care Act coverage under CMS rule
Modivcare CEO Strikes Optimistic Tone On Personal Care Segment, Final 80-20 Provision
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is Unlikely
Video: The Inflation Reduction Act in 2024 and Beyond

Share This Article